ANAHEIM, Calif.--(BUSINESS WIRE)--ClearFlow Inc. and Getinge (formerly Maquet Medical) are pleased to announce a renewal of the strategic partnership of the two companies in the USA to promote the PleuraFlow® Active Clearance Technology® (ACT®) System.
In a statement issued on April 5th, 2017, Paul Molloy, CEO at ClearFlow, and Raoul Quintero, CEO at Getinge N. America, announced the firms’ joint distribution agreement for the United States and the geographies that both companies will serve with their respective sales teams.
Raoul Quintero noted, “Getinge is pleased to offer ClearFlow’s high-end Active Clearance Technology as part of its cardio-thoracic product portfolio since it is entirely complementary to our market-leading product lines and enhances the clinical and economic value proposition for our customers.”
Paul Molloy added, “We are excited to be able to supply our proprietary technology through the Getinge sales channel in the USA. Getinge has excellent relationships with our customer base and, in addition, particularly strong agreements with both GPO’s and IDN’s, an ever-increasing component of our revenue. We expect the synergies between our companies to be of benefit to hospitals and patients and both companies.”
Getinge is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments and for life science companies and institutions. Based on first-hand experience and close partnerships, Getinge offers innovative healthcare solutions that improve every-day life for people, today and tomorrow.
ClearFlow, Inc. is an Anaheim, CA-based medical device company that has developed a patented active blood and fluid evacuation system to speed recovery, reduce complications and lower healthcare costs related to medical tube obstruction. The company has been awarded several prestigious awards, including the European Association of Cardiothoracic Surgeons Techno-College Innovation Award for worldwide innovation that has the potential to change the standard of care in heart and lung surgery, and the Innovations in Cardiovascular Interventions Award, among others.